Litcius/Paper detail

Implementing upfront mobile digital chest x-ray for tuberculosis diagnosis in India—feasibility and benefits

Bornali Datta, Ashish Prakash, David Ford, Jaya Prasad Tripathy, Pinky Goyal, Shreya Singh, Veena Singh, Anand Jaiswal, Naresh Trehan

2020Transactions of the Royal Society of Tropical Medicine and Hygiene13 citationsDOI

Abstract

BACKGROUND: The Tuberculosis (TB) Control Program in India changed the TB diagnostic algorithm and recommended sputum testing and chest x-ray (CXR) for presumptive TB up front. There is no experience of testing this algorithm in routine field settings. METHODS: In a public-private partnership (PPP), a private hospital provided mobile digital CXR services (mounted on a van) to complement the existing diagnostic services of sputum microscopy and GeneXpert testing. All presumptive TB patients (cough >2 weeks) underwent CXR and sputum microscopy, and GeneXpert testing if eligible (smear-negative CXR suggestive of TB). RESULTS: All 2973 presumptive TB patients underwent CXR and sputum microscopy; 471 (15.8%) had abnormal CXR findings suggestive of TB, 129 (4.3%) were smear positive and 17 were extrapulmonary TB. Of the remaining 325 with smear-negative and CXR suggestive of TB, 147 (45.2%) underwent GeneXpert testing, yielding 32 positives (21.8%). Of the remaining 178 with no GeneXpert test done, 106 (60.0%) had CXR definitely suggesting TB (clinically diagnosed TB). Thus a total of 284 cases of TB (161 microbiologically confirmed, 106 clinically diagnosed, 17 extrapulmonary TB) were identified, giving a potential diagnostic yield of 19.6%. CONCLUSIONS: Systematic screening with mobile digital X-ray service via a PPP model integrated into the national program is feasible and scalable with a high yield.

Topics & Concepts

GeneXpert MTB/RIFMedicineSputumTuberculosisInternal medicineSurgeryPathologyTuberculosis Research and EpidemiologyCOVID-19 diagnosis using AIDiagnosis and treatment of tuberculosis
Implementing upfront mobile digital chest x-ray for tuberculosis diagnosis in India—feasibility and benefits | Litcius